Case Report
Accepted on 30 Apr 2026
Obinutuzumab for Refractory Minimal Change Disease in Obese Patients: A Case Series
in Nephrology
Case Report
Accepted on 30 Apr 2026
in Nephrology
Original Research
Accepted on 30 Apr 2026
in Public Health Education and Promotion
Original Research
Accepted on 30 Apr 2026
in Neurorehabilitation
Systematic Review
Accepted on 30 Apr 2026
in Nephrology
Original Research
Accepted on 30 Apr 2026
in Interdisciplinary Physics
Case Report
Accepted on 30 Apr 2026
in Cardiovascular Pharmacology and Drug Discovery
Original Research
Accepted on 30 Apr 2026
in Sustainable Organizations
Original Research
Accepted on 30 Apr 2026
in Neurorehabilitation
Clinical Trial
Accepted on 30 Apr 2026
in Neurorehabilitation
Original Research
Accepted on 30 Apr 2026
in Blockchain Economics
Case Report
Accepted on 30 Apr 2026
in Hepatobiliary Diseases
Original Research
Accepted on 30 Apr 2026
in Pharmacoepidemiology
Original Research
Accepted on 30 Apr 2026
in Employee Well-being and Health
Brief Research Report
Accepted on 30 Apr 2026
in Higher Education
Review
Accepted on 30 Apr 2026
in Microbe and Virus Interactions with Plants
Original Research
Accepted on 30 Apr 2026
in Predictive Toxicology